FloridaMarijuana.net

JULY 8, 2018

The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. The psychological symptoms that develop because of the trauma affect mood, cognition, memories (both suppression and the inability to form new memories) and physical health.

Strains 190

Strains Indica Hybrid Research and Development 190

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Veriheal

JANUARY 19, 2022

While many have speculated that the skunk smell could be attributed to the terpenes , or aromatic compounds, of cannabis, the research team behind the study actually discovered a whole new class of volatile sulfur compounds (VSCs) to thank for the cannabis-skunk phenomenon. Studying the Chemical Makeup of Cannabis. Super Skunk. Sour Diesel.

Terpenes 98

Terpenes Strains Research and Development Media 98

The Cannigma

FEBRUARY 10, 2021

There is little relationship between blood or saliva limits on cannabis-impaired driving and the driver’s actual impairment, and law enforcement authorities must develop new detection methods, according to the findings of a new study. They also found that even 3.5 A ‘pressing need’ for better cannabis intoxication, impairment tests.

Research and Development 145

Research and Development Concentrates THC Vaping 145

Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. . – July 28, 2021) – PharmaDrug Inc.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Project CBD

MARCH 8, 2019

This explosion of interest in the use of cannabis and CBD for animals has led to the development of a multi-million dollar industry creating cannabis-based products for pets. In response, veterinarians and others concerned for patient safety promoted a change in state law. Related story.

Pets 218

Pets Legalization Hemp Extraction 218

LifeCannMD

AUGUST 30, 2024

In Florida, Medical Marijuana is legal and can be recommended for various conditions, including PTSD, provided the patient meets specific criteria. Cannabis research related to PTSD (post-traumatic stress disorder) is a growing field. While there is some promising research on cannabis for PTSD , the evidence is still developing.

Marijuana 110

Marijuana Research and Development Treatment THC 110

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

United Patients Group

SEPTEMBER 7, 2023

As the perception of medical marijuana evolves and an increasing number of individuals explore its therapeutic potential, it’s crucial to develop a comprehensive understanding of cannabis’ impact on bodily systems. One area of interest and ongoing research is the relationship between cannabis and the immune system.

Research and Development 111

Research and Development Conditions Cannabinoids Patients 111

Cannabis Law Report

JULY 19, 2021

Psychedelic medicine is a rapidly growing area and could be potential breakthrough therapeutics globally for psychiatric conditions such as depression, post-traumatic stress disorder (PTSD) and addiction. We don’t want to see research fall to the wayside as it has for cannabis, both in Canada and globally.

Clinical Trials 75

Clinical Trials Research and Development Hybrid Medicine 75

Veriheal

JANUARY 16, 2024

Let’s take a closer look at this new research around CBD for Cerebral Palsy and examine the extent of this trend and its implications for the future of CP management. It occurs due to abnormalities or damage to the developing brain before, during, or after birth. What is Cerebral Palsy?

Patients 116

Patients CBD Treatment Research and Development 116

The Cannigma

DECEMBER 20, 2021

terpenes ) may help treat a number of different skin conditions. Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling. Some of these have been identified as possible targets for the treatment of inflammatory skin conditions.

Terpenes 133

Terpenes Cannabinoids Topical Research and Development 133

PrestoDoctor

OCTOBER 23, 2023

However, research on the specific benefits and effects of THCjd is still in the works. However, due to its legal status and limited research, it is necessary to exercise caution and comply with local regulations when considering its use. It’s also worth mentioning that the safety of THCjd depends on various factors.

Cannabinoids 98

Cannabinoids Research and Development Safety THC 98

Cannabis Law Report

AUGUST 22, 2021

Company has also initiated preclinical studies aimed at treating psychologic and neurologic conditions. PsyBio intends to continue utilizing its resources to rapidly develop and test new drug candidates within this and other psychedelic categories in anticipation of launching future clinical trials. OXFORD, Ohio and COCONUT CREEK, Fla.,

Clinical Trials 98

Clinical Trials Research and Development Treatment Conditions 98

Cannabis Law Report

JULY 29, 2021

This move prompted changes in the regulations in different areas such as cannabis research, product labeling, beverage limits, and more. In this article, we’ve highlighted all the inputs gathered for further regulatory development. Product labeling conditions. So, let’s begin! Cannabis testing. Cannabis testing. What’s more?

Research and Development 105

Research and Development Legalization Environment Conditions 105

The Cannigma

MARCH 17, 2021

While emerging research is showing that cannabis may be effective in managing the symptoms of depression and other mental health disorders, research into its use for PPD remains largely unexplored and unpublished about. The need for more research is especially true for women suffering from PPD. Here’s what we know.

Research and Development 141

Research and Development Treatment Sleep Cannabis 141

Cannabis Law Report

MARCH 25, 2020

OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). Valencia has stewarded Sapphire in the development of its unique patent-pending pipeline.

Research and Development 45

Research and Development Supply Chain Pharmaceutical Clinical Trials 45

The Cannigma

JUNE 29, 2021

Though the distinction between these terms may seem trivial at first glance, it is in fact crucial for cannabis research, and therefore also for consumers and regulators as well. Researchers conducting survey based studies today often only have access to the THC concentration of the cannabis that their participants are using.

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Cannabis Law Report

MARCH 24, 2022

Rather, it’s a modest bipartisan piece of legislation that’s simply meant to promote research into marijuana. JUST IN: The Senate passed my bill with Senators Grassley and Schatz to cut red tape around the research process of marijuana and marijuana-derived medications. — Senator Dianne Feinstein (@SenFeinstein) March 24, 2022.

Research and Development 52

Research and Development Legislation Patients Safety 52

Cannabis Law Report

AUGUST 22, 2021

OTCQB: SILO), a development-stage biopharmaceutical company focused on the therapeutic potential of psychedelics, recently announced that the U.S. The company’s efforts to secure patents are the cornerstone of its strategy to develop and license therapeutics. million, subject to restrictions and other conditions on their holdings.

Clinical Trials 105

Clinical Trials Research and Development Safety Treatment 105

MMJ Recs

JUNE 25, 2024

Cannabis consumption for medical purposes has gained widespread acceptance in recent years, thanks to growing research supporting its efficacy in alleviating symptoms associated with numerous medical conditions. Consider your lifestyle and treatment goals when choosing a consumption method.

Consumption 52

Consumption Conditions Chronic Pain Tincture 52

Cannabis Law Report

AUGUST 5, 2021

Psychedelics are quickly emerging as alternative methods of treatment for mental illnesses and neurodegenerative conditions — particularly in countries such as Canada. What’s more, over the coming years psychedelics will continue to gain acceptance for treating these conditions which will also contribute to that market growth.

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

Cannabis Law Report

AUGUST 10, 2021

The UK is a significant country for us for many reasons, and we are proud to be able to offer a medicine, that has been developed and is manufactured here, to even more patients across the UK. The safety profile observed was consistent with findings from previous studies, with no new safety risks identified.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

MMJ Recs

JULY 11, 2024

In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers. It can be caused by a variety of factors, including medical conditions, psychological issues, or environmental factors.

Sleep 111

Sleep Treatment Research and Development Therapy 111

Cannabis Law Report

JULY 6, 2021

Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety. Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of ?9-tetrahydrocannabinol for beta testing.

Research and Development 105

Research and Development THC Safety Events 105

United Patients Group

JULY 7, 2023

In recent years, there has been a growing interest in the use of medical cannabis to manage a variety of health conditions. Medical cannabis, also known as medical marijuana, refers to the use of the cannabis plant or its extracts to treat symptoms of disease or other medical conditions.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

MMJ Recs

NOVEMBER 20, 2023

These two cannabinoids represent just a fraction of the compounds within the cannabis plant, and ongoing research continues to uncover the potential of other lesser-known cannabinoids. Additionally, they may help slow the growth of certain types of cancer cells, though further research is needed.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 111

Consumption Patients Research and Development Data 111

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. 561-627-9455. 917-562-9610.

DEA 51

DEA Clinical Trials THC Research and Development 51

MMJ Recs

JULY 9, 2024

Living with chronic conditions such as Multiple Sclerosis (MS) is profoundly challenging and impacts various aspects of daily life. Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

NOVEMBER 29, 2021

Medical marijuana has received more attention from legislators, scientists, researchers, clinicians, and the general public than any other topic. . It has been shown that medicinal marijuana may help alleviate the symptoms of some conditions, provided that doctors keep a close eye on how much is taken and how often it’s used.

Legalization 52

Legalization Research and Development Decriminalization Marijuana 52

Cannabis Law Report

FEBRUARY 28, 2022

The Board will also develop a long-term strategic plan for ensuring that psilocybin services will become and remain a safe, accessible and affordable therapeutic option for all persons 21 years of age and older in this state for whom psilocybin may be appropriate and monitor and study federal laws, regulations and policies regarding psilocybin.

Research and Development 105

Research and Development Safety Policy Conditions 105

Cannabis Law Report

OCTOBER 6, 2021

The lab currently holds a 56 Research Exemption for chemistry analytics on psilocybin mushrooms. Additionally, the lab has applied for a Dealer’s License and intends to eventually commercialize its psilocybin research and associated intellectual property (IP) for medical and research purposes.

Research and Development 52

Research and Development Extraction Treatment Safety 52

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

More than half the states in the country have now legalized medical cannabis for patients with qualifying conditions and several more have gone so far as to legalize recreational marijuana for adults. GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Lennox-Gestaut Syndrome.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Veriheal

MARCH 21, 2022

At the end of November 2021, the CDC’s National Institute for Occupational Safety and Health (NIOSH) announced that there are deep-seated risks associated with driving a motor vehicle under the influence of cannabis’ psychotropic compound tetrahydrocannabinol (THC). Because marijuana use is on the rise for adults in the U.S.,

Policy 98

Policy Blood Pressure Research and Development Concentrates 98